Literature DB >> 18710775

Urine is necessary to provoke bladder inflammation in protamine sulfate induced urothelial injury.

Roberto Soler1, Homero Bruschini, Marcos P Freire, Maria T Alves, Miguel Srougi, Valdemar Ortiz.   

Abstract

PURPOSE: The bladder is normally impermeable to possible hostile environmental factors and toxic urinary wastes. Any disruption of the permeability barrier would permit the leakage of urine constituents into the underlying cells layers and subsequent inflammation. Protamine sulfate, which increases urothelial permeability, is used in experimental models of cystitis. We examined whether protamine sulfate alone could cause bladder inflammation or if the association of protamine sulfate and urine is needed for this condition.
MATERIALS AND METHODS: Female Wistar rats (Center for the Development of Experimental Models for Medicine and Biology, Federal University of São Paulo, São Paulo, Brazil) had the bladder catheterized and instilled with protamine sulfate (10 mg) or sterile saline for 30 minutes. To exclude urine other groups of rats underwent bilateral nephrectomy and the same procedure was used. One day after instillation the bladders were removed for histopathology. Edema and vascular congestion were graded from 0-none to 3-severe. Polymorphonuclear and mast cells were counted. The Kruskal-Wallis test was performed for statistical analysis.
RESULTS: Intravesical instillation of protamine sulfate in nonnephrectomized rats led to inflammation, in contrast to findings in rats instilled with saline. On the other hand, nephrectomized rats showed no inflammatory changes following the instillation of protamine sulfate or saline. The mast cell count was similar in all groups.
CONCLUSIONS: Bladder inflammation in this experimental model of urothelial injury was not due to protamine sulfate alone. The association of protamine sulfate and urine was necessary to trigger the inflammatory cascade. Thus, urine indeed has an important role in the development of bladder inflammation in an environment of higher urothelial permeability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18710775     DOI: 10.1016/j.juro.2008.06.006

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  In the absence of overt urothelial damage, chondroitinase ABC digestion of the GAG layer increases bladder permeability in ovariectomized female rats.

Authors:  Robert E Hurst; Samuel Van Gordon; Karl Tyler; Bradley Kropp; Rheal Towner; HsuehKung Lin; John O Marentette; Jane McHowat; Ehsan Mohammedi; Beverley Greenwood-Van Meerveld
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-24

2.  Correlative study of functional and structural regeneration of urothelium after chitosan-induced injury.

Authors:  Andreja Erman; Mojca Kerec Kos; Simon Žakelj; Nataša Resnik; Rok Romih; Peter Veranič
Journal:  Histochem Cell Biol       Date:  2013-04-04       Impact factor: 4.304

3.  Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage "leaky bladder" model of cystitis.

Authors:  Christopher D Engles; Paul J Hauser; Shivon N Abdullah; Daniel J Culkin; Robert E Hurst
Journal:  Urology       Date:  2011-12-02       Impact factor: 2.649

4.  Imidazolium salts as small-molecule urinary bladder exfoliants in a murine model.

Authors:  Patrick O Wagers; Kristin M Tiemann; Kerri L Shelton; William G Kofron; Matthew J Panzner; Karen L Wooley; Wiley J Youngs; David A Hunstad
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

5.  Contrast enhanced magnetic resonance imaging as a diagnostic tool to assess bladder permeability and associated colon cross talk: preclinical studies in a rat model.

Authors:  Rheal A Towner; Nataliya Smith; Debra Saunders; Samuel B Van Gordon; Amy B Wisniewski; Karl R Tyler; Beverley Greenwood-Van Meerveld; Robert E Hurst
Journal:  J Urol       Date:  2014-11-14       Impact factor: 7.450

6.  Decreased urinary glycosaminoglycan excretion following alfuzosin treatment on ureteral stent-related symptoms: a prospective, randomized, placebo-controlled study.

Authors:  Shucheng Liu; Ying Yu; Yang Gao; Xiong Yang; Zili Pang
Journal:  Urolithiasis       Date:  2015-08-05       Impact factor: 3.436

7.  Protamine sulfate induced bladder injury protects from distention induced bladder pain.

Authors:  Kristina M Stemler; Lara W Crock; H Henry Lai; Jason C Mills; Robert W Gereau; Indira U Mysorekar
Journal:  J Urol       Date:  2012-11-20       Impact factor: 7.450

8.  A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study.

Authors:  Susan Keay; Samantha Leitzell; Ashley Ochrzcin; George Clements; Min Zhan; David Johnson
Journal:  BMC Urol       Date:  2012-06-08       Impact factor: 2.264

9.  The role of TSG-6 and uroplakin III in bladder pain syndrome/ interstitial cystitis in rats and humans.

Authors:  Yi-Song Lv; Rui Gao; Qing-Ming Lin; Tao Jiang; Qin Chen; Song-Xi Tang; Hou-Ping Mao; Hui-Liang Zhou; Lin-Sheng Cao
Journal:  Iran J Basic Med Sci       Date:  2017-11       Impact factor: 2.699

Review 10.  The role(s) of cytokines/chemokines in urinary bladder inflammation and dysfunction.

Authors:  Eric J Gonzalez; Lauren Arms; Margaret A Vizzard
Journal:  Biomed Res Int       Date:  2014-03-12       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.